| Literature DB >> 31861315 |
Wei Ye1, Taomei Liu1, Weimin Zhang1, Muzi Zhu1, Zhaoming Liu1, Yali Kong1, Shan Liu1.
Abstract
Marine toxins cause great harm to human health through seafood, therefore, it is urgent to exploit new marine toxins detection methods with the merits of high sensitivity and specificity, low detection limit, convenience, and high efficiency. Aptasensors have emerged to replace classical detection methods for marine toxins detection. The rapid development of molecular biological approaches, sequencing technology, material science, electronics and chemical science boost the preparation and application of aptasensors. Taken together, the aptamer-based biosensors would be the best candidate for detection of the marine toxins with the merits of high sensitivity and specificity, convenience, time-saving, relatively low cost, extremely low detection limit, and high throughput, which have reduced the detection limit of marine toxins from nM to fM. This article reviews the detection of marine toxins by aptamer-based biosensors, as well as the selection approach for the systematic evolution of ligands by exponential enrichment (SELEX), the aptamer sequences. Moreover, the newest aptasensors and the future prospective are also discussed, which would provide thereotical basis for the future development of marine toxins detection by aptasensors.Entities:
Keywords: SELEX; aptamers; biosensors; detection; marine toxins
Mesh:
Substances:
Year: 2019 PMID: 31861315 PMCID: PMC7020455 DOI: 10.3390/toxins12010001
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1The structures of representative marine toxins.
Figure 2The detection of marine toxins by aptamer biosensors.
The classification, toxicity, toxic mechanism and aptamer-based detection of marine toxins.
| Marine Toxins | Toxicity (LD or LD50) Towards Mice | Toxic Mechanism | Aptasensor Type | LOD | LRD | Aptamer Sequences | The Immobilization Method | Reference |
|---|---|---|---|---|---|---|---|---|
| STX | LD50 = 10 μg/kg | binds to sodium channel proteins | graphene quantum dots | 0.1 ng/μL | 0.1–100 ng/μL | CTTTTTACAAAATTCTCTTTTTACCTATATTATGAACAGA | Physical absorption of MRGO | [ |
| TTX | LD50 = 10 μg/kg | blocks nerve conduction | aptamer fluorochrome (EvaGreen) | 1 μM | TCAAATTTTCGTCTACTCAATCTTTCTGTCTTATC | ___ | [ | |
| OA | LD50 = 166 μg/kg | activating cAMP mediator system, inhibiting PP1A, PP2A | Fluorescence combined with rolling cycle amplification | 10 pg/mL | 0.01–100 ng/mL | GGTCACCAACAACAGGGAGCGCTACGCGAAGGGTCAATGTGACGTCATGCGGATGTGTGG | The binding of biotin-labeled aptamer to streptavidin-catalase complex | [ |
| PTX | LD = 2.3-31.5 μg/kg | activating cells to release potassium ions rapidly | Biolayer Interferometry (AR2G biosensor) | 0.04 pg/mL | 200–700 pg/mL | ACCGACCGTGCTGGACTCAGGAGGTGGTGGGGACTTTGCTTGTACTGGGCGCCCGGTTGAAACTATGAGCGAGCCTGGCG | EDC/NHS method | [ |
| BTX | LD50 = 55.36 mg/kg | open and activate sodium channel | label-free impedimetric biosensor (electrochemical biosensor) | 106 pg/mL | GGCCACCAAACCACACCGTCGCAACCGCGAGAACCGAAGTAGTGATCATGTCCCTGCGTG | The BTX was immobilized on cysteamine-modified gold electrodes | [ | |
| DA | LD50 = 10 mg/kg | bind with the receptor of glutamic neurotransmitter | ___ | ___ | ___ | [ | ||
| DTX-2 | LD50 = 338 μg/kg | inhibiting PP2A | ___ | ___ | ___ | ___ | [ | |
| CYN | LD50 = 200 μg/kg | Inhibit the synthesis of protein, glutathione and P450 activity | Label free impedimetric biosensor (Graphene-Based biosensor) | 1.9 pM | GGCATCAGGCAACAACCGATGGTCCGGCCACCCTAACAACCAGCCCACCCACCACCCCGCCG | utilizs an unlabeled aptamer noncovalently assembled on a graphene electrode | [ |
“_” means no aptamer sequences were reported.
Figure 3The scheme of newest developed aptamer-based biosensors.